HIV Care Formula Grants
Open Opportunities (1)
Live Grants.gov opportunities funded under this program — you can apply now.
- Ryan White HIV/AIDs Program Part B States/Territories Supplemental Grant Program Deadline: Jun 24, 2026 · up to $9M
See all grants from Health Resources and Services Administration →
Program Funding
Annual program obligations reported to SAM.gov.
Who has received this funding
Organizations awarded under CFDA 93.917 (USAspending.gov).
- Public Health, California Department Of $1,011,963,420
- Health Research, Inc. $932,375,361
- Florida Department Of Health $867,398,557
- Department Of State Health Services $841,300,580
- State Of Georgia Department Of Public Health $472,892,060
- Department Of Public Health Illinois $324,850,807
- Health, New Jersey Department Of $263,840,228
- North Carolina Department Of Health & Human Services $257,869,222
- Pennsylvania Department Of Health $254,532,602
- Maryland Department Of Health $235,121,527
Funded Projects
Examples of what this program has supported.
Nearly 602,000 people with HIV in the U.S. received life-saving care, medication, and essential support services through the Ryan White HIV/AIDS Program, representing over half of those with diagnosed HIV in the U.S. This is an increase of nearly 26,000 clients.
More than 91% of Ryan White HIV/AIDS Program patients receiving HIV medical care were virally suppressed in 2024. This is up from 69.5% of patients virally suppressed in 2010 and significantly higher than the 67.2% virally suppressed nationally among all people with diagnosed HIV.
More than 47% of Ryan White HIV/AIDS Program clients are aged 50 years and older, demonstrating the program’s success in supporting older clients.
Program Objective
The purpose of this program is to assist states and territories in developing and/or enhancing access to a comprehensive continuum of high-quality HIV care and treatment for low-income people with HIV.
Eligibility
Eligible Applicants
- U.S. State Government
- U.S. Territory Government
Eligible applicants are: The 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
Beneficiaries
- Unrestricted by Individual Type
Individuals with HIV.
How to Apply
Award Procedure
As required by the legislation, RWHAP Part B Base, ADAP Base, and Emerging Communities formula awards are based on the number of reported living cases of HIV/AIDS in the State or Territory in the most recent calendar year as confirmed by CDC and submitted to HRSA. Similarly, for recipients applying for Minority AIDS Initiative (MAI) formula funds, awards are based on the number of reported living minority HIV/AIDS cases for the most recent calendar year as confirmed by CDC and submitted to HRSA. ADAP Supplemental grants are awarded by formula based on living HIV/AIDS cases to states which meet any of the criteria listed in that section of the NOFO for the purpose of providing medications or insurance assistance for people with HIV. The ADAP Emergency Relief Funds (ERF) awards, for the purpose of cost containment activities for preventing, reducing or eliminating ADAP waiting lists, are disbursed via a formula based on a competitive application process with need-based criteria listed in the NOFO. In a separate, competitive application process, RWHAP Part B Supplemental funds are disbursed based on criteria specified by the legislation. All qualified applications for ADAP ERF and Part B Supplemental funds will be forwarded to an objective review committee (ORC). Based on the recommendations of the ORC, the HRSA program official with delegated authority is responsible for final selection and funding decisions. Notification is made in writing by a Notice of Award (NOA).
Decision Timeline
- Approval: From 120 to 180 days
Program details & compliance
Description
The purpose of this program is to assist states and territories in developing and/or enhancing access to a comprehensive continuum of high-quality HIV care and treatment for low-income people with HIV.
Mission Categories
Primary: General Health and Medical
Other categories:
General Health and Medical
Use of Funds
Allowed Uses
Not less than 75 percent of grant funds remaining after reserving funds for administration and clinical quality management must be used to provide core medical services. Core medical services include outpatient ambulatory health services, AIDS Drug Assistance Program (ADAP), local pharmaceutical assistance, oral health care, health insurance premium and cost-sharing, home health care, home and community-based health services, hospice services, early intervention services, medical nutritional therapy, substance abuse outpatient care, mental health services, and medical case management, including treatment adherence services. The remaining 25percent may be used for support services, including non-medical case management, childcare services, emergency financial assistance, food bank/home delivered meals, health education/risk reduction, housing services, linguistic services, psychosocial support services, rehabilitation services, respite care, and transportation that support a person with HIV to achieve better health outcomes. Funds may be used to establish and operate HIV Care Consortia that shall conduct planning, funding, monitoring, and reporting on behalf of the recipient. HIV Care Consortia are categorized under the support services category. A State/Territory shall use a percentage of the grant, determined by the percentage of women, infants, children, and youth with HIV/AIDS in the State, to provide core medical and support services to infants, children, youth, and women with HIV. Funds may not be used to make payments for any item or service to the extent that payment has been made, or can reasonably be expected to be made, with respect to that item or service under any State compensation program, insurance policy, Federal or State health benefits program or by any entity that provides health services on a prepaid basis (except for a program administered by or providing the services to the Indian Health Service). Funds may not be used to purchase or improve land, or to purchase, construct or make permanent improvement to any building except for minor remodeling. Funds may not be used to make cash payments to intended recipients of Ryan White HIV/AIDS Program (RWHAP) services. Funds may not be used for pre-exposure prophylaxis (PrEP) or non-occupational post-exposure prophylaxis (nPEP) medications or the related medical services. Additionally, the purchase of sterile needles or syringes for the purposes of hypodermic injection of any illegal drug is not allowable. Some aspects of Syringe Services Programs are allowable with HRSA's prior approval and in compliance with HHS and HRSA policy (see: https://www.hiv.gov/federal-response/policies-issues/syringe-services-programs). A State/Territory may not use more than 10 percent of amounts received under this grant for administration. However, if a State/Territory receives the minimum allotment, it may use more than 10% of the award if it is required to support one full-time equivalent employee for these activities. A State/Territory may not use more than 10 percent of amounts received under the grant for planning and evaluation activities. When combined, a State/Territory may not use more than 15 percent on administration, planning and evaluation. Clinical quality management (CQM) expenditures are not included in the administrative or planning and evaluation costs but are subject to a cap of the lesser of 5 percent of amounts received under the grant or $3,000,000. In addition, the aggregate total of administrative expenditures for subrecipients, including all indirect costs, may not exceed ten (10) percent of the aggregate amount of all subawards. Seventy-five (75) percent of grant funds must be obligated within 120 days of the budget period start date.
Required Documentation
Applicants should review the individual HRSA Notice of Funding Opportunity (NOFO) issued under this Assistance Listing for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. All HRSA awards are subject to the Uniform Administrative Requirements, Cost Principles, and Audit Requirements at 2 CFR 200 and modifications at 2 CFR 300. Subpart E - Cost Principles applies to this program.
Matching Requirements
This program has matching requirements; see agency NOFO for further details.
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements
Formula
Title XXVI of the Public Health Services (PHS) Act, Part B Subpart I, Section 2618 Public Law Statutory Formula: RWHAP Part B Base, ADAP Base and Emerging Communities awards are based on the number of reported living cases of HIV/AIDS cases in the State or Territory in the most recent calendar year as confirmed by CDC and submitted to HRSA. Similarly, for recipients applying for MAI formula funds, awards are based on the number of reported and confirmed living minority cases of HIV/AIDS for the most recent calendar year submitted to HRSA by CDC. The most recently completed calendar year ended December 31, 2024. ADAP Supplemental grants are awarded by formula based on living HIV/AIDS cases to states which meet any of the criteria listed in that section of the NOFO for the purpose of providing medications or insurance assistance for people with HIV.